CN113481180A - Alkaline thermophilic inorganic pyrophosphatase and application thereof in enhancing polymerase chain reaction and UDP-galactose synthesis reaction - Google Patents
Alkaline thermophilic inorganic pyrophosphatase and application thereof in enhancing polymerase chain reaction and UDP-galactose synthesis reaction Download PDFInfo
- Publication number
- CN113481180A CN113481180A CN202110765804.0A CN202110765804A CN113481180A CN 113481180 A CN113481180 A CN 113481180A CN 202110765804 A CN202110765804 A CN 202110765804A CN 113481180 A CN113481180 A CN 113481180A
- Authority
- CN
- China
- Prior art keywords
- ppase
- thermophilic
- reaction
- alkaline
- ton1914
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010009595 Inorganic Pyrophosphatase Proteins 0.000 title claims abstract description 94
- 238000003752 polymerase chain reaction Methods 0.000 title claims abstract description 41
- HSCJRCZFDFQWRP-ABVWGUQPSA-N UDP-alpha-D-galactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-ABVWGUQPSA-N 0.000 title claims abstract description 18
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 title claims abstract description 18
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 9
- 238000003786 synthesis reaction Methods 0.000 title claims description 8
- 102000009617 Inorganic Pyrophosphatase Human genes 0.000 title abstract description 17
- 102100027050 Inorganic pyrophosphatase Human genes 0.000 claims abstract description 78
- 238000006243 chemical reaction Methods 0.000 claims abstract description 49
- 239000002773 nucleotide Substances 0.000 claims abstract description 5
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 39
- 239000012634 fragment Substances 0.000 abstract description 24
- 108090000623 proteins and genes Proteins 0.000 abstract description 15
- 241000894006 Bacteria Species 0.000 abstract description 7
- 230000003321 amplification Effects 0.000 abstract description 6
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 6
- 241000205188 Thermococcus Species 0.000 abstract description 4
- 208000012839 conversion disease Diseases 0.000 abstract description 3
- 230000002194 synthesizing effect Effects 0.000 abstract description 3
- -1 nurineus Species 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract description 2
- 101710167959 Putative UTP-glucose-1-phosphate uridylyltransferase Proteins 0.000 abstract 1
- 102000048175 UTP-glucose-1-phosphate uridylyltransferases Human genes 0.000 abstract 1
- 230000001909 effect on DNA Effects 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 description 23
- 102000004190 Enzymes Human genes 0.000 description 22
- 239000000047 product Substances 0.000 description 20
- 239000013612 plasmid Substances 0.000 description 16
- 238000012408 PCR amplification Methods 0.000 description 14
- 238000011529 RT qPCR Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 239000006227 byproduct Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000872 buffer Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000006366 phosphorylation reaction Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 102000018120 Recombinases Human genes 0.000 description 3
- 108010091086 Recombinases Proteins 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- 102000000102 UDP-sugar pyrophosphorylases Human genes 0.000 description 2
- 108050008412 UDP-sugar pyrophosphorylases Proteins 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 108010053725 prolylvaline Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- CKLDHDOIYBVUNP-KBIXCLLPSA-N Ala-Ile-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O CKLDHDOIYBVUNP-KBIXCLLPSA-N 0.000 description 1
- NLYYHIKRBRMAJV-AEJSXWLSSA-N Ala-Val-Pro Chemical compound C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N NLYYHIKRBRMAJV-AEJSXWLSSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- OHYQKYUTLIPFOX-ZPFDUUQYSA-N Arg-Glu-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OHYQKYUTLIPFOX-ZPFDUUQYSA-N 0.000 description 1
- HPSVTWMFWCHKFN-GARJFASQSA-N Arg-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O HPSVTWMFWCHKFN-GARJFASQSA-N 0.000 description 1
- NTWOPSIUJBMNRI-KKUMJFAQSA-N Asn-Lys-Tyr Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NTWOPSIUJBMNRI-KKUMJFAQSA-N 0.000 description 1
- FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 1
- LDLZOAJRXXBVGF-GMOBBJLQSA-N Asp-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)O)N LDLZOAJRXXBVGF-GMOBBJLQSA-N 0.000 description 1
- XUVTWGPERWIERB-IHRRRGAJSA-N Asp-Pro-Phe Chemical compound N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O XUVTWGPERWIERB-IHRRRGAJSA-N 0.000 description 1
- GGRSYTUJHAZTFN-IHRRRGAJSA-N Asp-Pro-Tyr Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O GGRSYTUJHAZTFN-IHRRRGAJSA-N 0.000 description 1
- FIRWLDUOFOULCA-XIRDDKMYSA-N Asp-Trp-Lys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N FIRWLDUOFOULCA-XIRDDKMYSA-N 0.000 description 1
- AWPWHMVCSISSQK-QWRGUYRKSA-N Asp-Tyr-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O AWPWHMVCSISSQK-QWRGUYRKSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241001200922 Gagata Species 0.000 description 1
- MQANCSUBSBJNLU-KKUMJFAQSA-N Gln-Arg-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MQANCSUBSBJNLU-KKUMJFAQSA-N 0.000 description 1
- XMWNHGKDDIFXQJ-NWLDYVSISA-N Gln-Thr-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O XMWNHGKDDIFXQJ-NWLDYVSISA-N 0.000 description 1
- FHPXTPQBODWBIY-CIUDSAMLSA-N Glu-Ala-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FHPXTPQBODWBIY-CIUDSAMLSA-N 0.000 description 1
- JRCUFCXYZLPSDZ-ACZMJKKPSA-N Glu-Asp-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O JRCUFCXYZLPSDZ-ACZMJKKPSA-N 0.000 description 1
- CGOHAEBMDSEKFB-FXQIFTODSA-N Glu-Glu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O CGOHAEBMDSEKFB-FXQIFTODSA-N 0.000 description 1
- GGJOGFJIPPGNRK-JSGCOSHPSA-N Glu-Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)N)C(O)=O)=CNC2=C1 GGJOGFJIPPGNRK-JSGCOSHPSA-N 0.000 description 1
- ZWABFSSWTSAMQN-KBIXCLLPSA-N Glu-Ile-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O ZWABFSSWTSAMQN-KBIXCLLPSA-N 0.000 description 1
- MFNUFCFRAZPJFW-JYJNAYRXSA-N Glu-Lys-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MFNUFCFRAZPJFW-JYJNAYRXSA-N 0.000 description 1
- MHHUEAIBJZWDBH-YUMQZZPRSA-N Gly-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN MHHUEAIBJZWDBH-YUMQZZPRSA-N 0.000 description 1
- OQQKUTVULYLCDG-ONGXEEELSA-N Gly-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(O)=O OQQKUTVULYLCDG-ONGXEEELSA-N 0.000 description 1
- JJGBXTYGTKWGAT-YUMQZZPRSA-N Gly-Pro-Glu Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O JJGBXTYGTKWGAT-YUMQZZPRSA-N 0.000 description 1
- YOBGUCWZPXJHTN-BQBZGAKWSA-N Gly-Ser-Arg Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YOBGUCWZPXJHTN-BQBZGAKWSA-N 0.000 description 1
- FFJQHWKSGAWSTJ-BFHQHQDPSA-N Gly-Thr-Ala Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O FFJQHWKSGAWSTJ-BFHQHQDPSA-N 0.000 description 1
- SGLXGEDPYJPGIQ-ACRUOGEOSA-N His-Phe-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N SGLXGEDPYJPGIQ-ACRUOGEOSA-N 0.000 description 1
- HVWXAQVMRBKKFE-UGYAYLCHSA-N Ile-Asp-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HVWXAQVMRBKKFE-UGYAYLCHSA-N 0.000 description 1
- UWLHDGMRWXHFFY-HPCHECBXSA-N Ile-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@@H]1C(=O)O)N UWLHDGMRWXHFFY-HPCHECBXSA-N 0.000 description 1
- ZUPJCJINYQISSN-XUXIUFHCSA-N Ile-Met-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)N ZUPJCJINYQISSN-XUXIUFHCSA-N 0.000 description 1
- NLZVTPYXYXMCIP-XUXIUFHCSA-N Ile-Pro-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O NLZVTPYXYXMCIP-XUXIUFHCSA-N 0.000 description 1
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
- OGUUKPXUTHOIAV-SDDRHHMPSA-N Leu-Glu-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N OGUUKPXUTHOIAV-SDDRHHMPSA-N 0.000 description 1
- HGFGEMSVBMCFKK-MNXVOIDGSA-N Leu-Ile-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O HGFGEMSVBMCFKK-MNXVOIDGSA-N 0.000 description 1
- UGTZHPSKYRIGRJ-YUMQZZPRSA-N Lys-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O UGTZHPSKYRIGRJ-YUMQZZPRSA-N 0.000 description 1
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 1
- IHITVQKJXQQGLJ-LPEHRKFASA-N Met-Asn-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N IHITVQKJXQQGLJ-LPEHRKFASA-N 0.000 description 1
- ANCPZNHGZUCSSC-ULQDDVLXSA-N Met-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCSC)CC1=CC=C(O)C=C1 ANCPZNHGZUCSSC-ULQDDVLXSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- 238000013494 PH determination Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- HCTXJGRYAACKOB-SRVKXCTJSA-N Phe-Asn-Asp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HCTXJGRYAACKOB-SRVKXCTJSA-N 0.000 description 1
- ISYSEOWLRQKQEQ-JYJNAYRXSA-N Phe-His-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O ISYSEOWLRQKQEQ-JYJNAYRXSA-N 0.000 description 1
- YKUGPVXSDOOANW-KKUMJFAQSA-N Phe-Leu-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YKUGPVXSDOOANW-KKUMJFAQSA-N 0.000 description 1
- XYHMFGGWNOFUOU-QXEWZRGKSA-N Pro-Ile-Gly Chemical compound OC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 XYHMFGGWNOFUOU-QXEWZRGKSA-N 0.000 description 1
- BUEIYHBJHCDAMI-UFYCRDLUSA-N Pro-Phe-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O BUEIYHBJHCDAMI-UFYCRDLUSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241001054881 Thermococcus onnurineus NA1 Species 0.000 description 1
- XYFISNXATOERFZ-OSUNSFLBSA-N Thr-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N XYFISNXATOERFZ-OSUNSFLBSA-N 0.000 description 1
- LECUEEHKUFYOOV-ZJDVBMNYSA-N Thr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)[C@@H](C)O LECUEEHKUFYOOV-ZJDVBMNYSA-N 0.000 description 1
- KRCPXGSWDOGHAM-XIRDDKMYSA-N Trp-Lys-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O KRCPXGSWDOGHAM-XIRDDKMYSA-N 0.000 description 1
- BIWVVOHTKDLRMP-ULQDDVLXSA-N Tyr-Pro-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O BIWVVOHTKDLRMP-ULQDDVLXSA-N 0.000 description 1
- RGYCVIZZTUBSSG-JYJNAYRXSA-N Tyr-Pro-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O RGYCVIZZTUBSSG-JYJNAYRXSA-N 0.000 description 1
- PYXQBKJPHNCTNW-CYDGBPFRSA-N Val-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](C(C)C)N PYXQBKJPHNCTNW-CYDGBPFRSA-N 0.000 description 1
- RYQUMYBMOJYYDK-NHCYSSNCSA-N Val-Pro-Glu Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RYQUMYBMOJYYDK-NHCYSSNCSA-N 0.000 description 1
- BGXVHVMJZCSOCA-AVGNSLFASA-N Val-Pro-Lys Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)N BGXVHVMJZCSOCA-AVGNSLFASA-N 0.000 description 1
- QPJSIBAOZBVELU-BPNCWPANSA-N Val-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N QPJSIBAOZBVELU-BPNCWPANSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010070944 alanylhistidine Proteins 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000011840 criminal investigation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 108010079547 glutamylmethionine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 108010017391 lysylvaline Proteins 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108010014614 prolyl-glycyl-proline Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940048084 pyrophosphate Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/305—Pyrimidine nucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
- C12Y306/01—Hydrolases acting on acid anhydrides (3.6) in phosphorus-containing anhydrides (3.6.1)
- C12Y306/01001—Inorganic diphosphatase (3.6.1.1)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
An alkaline thermophilic Inorganic pyrophosphatase (Inorganic pyrophosphatase, PPase, EC3.6.1.1) and its application in the Reaction of enhancing Polymerase Chain Reaction (PCR) and synthesizing UDP-galactose belong to the technical field of biological engineering. The alkaline thermophilic inorganic pyrophosphatase is obtained by screening thermophilic bacteria Thermococcus ornurineus NA1, is marked as alkaline thermophilic PPase Ton1914, and the nucleotide sequence of the alkaline thermophilic inorganic pyrophosphatase is shown as SEQ ID No. 1. The result shows that the alkaline thermophilic PPase Ton1914 has obvious promotion effect on the amplification efficiency of DNA fragments with different lengths, and has more obvious amplification effect on DNA templates with small gene length. Alkaline thermophilic PPase Ton1914 is added into UDP-galactose generated by the reaction of 1-P-galactose catalyzed by UDP-glucose pyrophosphorylase TTE0732 and UTP, so that the reaction conversion rate can be further improved.
Description
Technical Field
The invention belongs to the technical field of biological engineering, and particularly relates to alkaline thermophilic Inorganic pyrophosphatase (Inorganic pyrophosphatase, PPase, EC3.6.1.1) and application thereof in Polymerase Chain Reaction (PCR) Reaction enhancement and UDP-galactose synthesis.
Background
The product inhibition effect refers to a phenomenon that the terminal or by-product can reduce the enzymatic activity of the catalytic key step, and is one of the important factors which currently cause the reduction of the reaction yield of the natural enzyme, and has adverse effects on industrial production. In a living body, various vital activities such as DNA and RNA polymerization, amino acid activation, fatty acid oxidation, and synthesis of coenzyme, cellulose, starch require phosphorylation reaction to maintain a balance, and the phosphorylation reaction inevitably produces a by-Product Pyrophosphate (PPi) so that the phosphorylation reaction efficiency is suppressed. For example, in PCR, the reaction process generates a large amount of PPi to reduce the reaction efficiency, and thus, the elimination of PPi as a by-product can drive the forward movement of the phosphorylation reaction.
PCR is a molecular biology technique that can amplify a large number of DNA fragments using a small amount of DNA fragments. Due to the characteristics of high sensitivity, strong specificity, low purity requirement, simplicity and rapidness, the method plays a vital role in aspects of life research, clinical medicine, criminal investigation and the like. PCR generates a large amount of PPi as a by-product, thereby preventing forward progress of PCR, and thus, elimination of PPi is essential to improve PCR amplification efficiency. Since the reaction condition of PCR is high temperature and alkaline environment, the chemical method for removing PPi under acidic condition has poor effect. PPase is generally used for hydrolyzing PPi biologically, but the high temperature reaction environment of PCR can greatly reduce or even inactivate the activity of enzyme. Therefore, the development of new enzymes or other PCR enhancers that are resistant to high temperatures and alkali has been a hot spot. For example, patent CN104862288A uses a polymer-protein coupling technology to modify an N-isopropylacrylamide (PNIPAM) near the active center of a protein, the polymer has temperature responsiveness, can enhance the thermal stability of the protein to make the normal temperature protein adapt to the high temperature PCR condition, and simultaneously hydrolyzes PPi to achieve the effect of enhancing PCR, the final result shows that the thermal stability of the method at 60 ℃ is increased by 88% compared with the wild type, and the PCR efficiency is also significantly increased. Development of thermophilic PPase has been little achieved in recent years, for example, CN106834249A patent improves expression efficiency and thermostability of thermophilic PPase through mutation. However, no patent on the improvement of PCR amplification efficiency by thermophilic PPase has been reported. There are also commercially available thermophilic ppases, such as PPase extracted from e.g. the species hepacius stearothermophilus, but it is expensive and has limited purchasing channels. Therefore, the development of a highly efficient thermostable PPase is urgently needed. The invention clones and purifies thermophilic PPase from reduced sulfur hyperthermophilus, Thermococcus ornurineus NA1, and applies the thermophilic PPase to remove the byproduct PPi in PCR of DNA templates with different lengths, thereby effectively improving the PCR amplification efficiency. At present, no patent for improving PCR amplification efficiency by thermophilic PPase is found.
Disclosure of Invention
The invention aims to provide alkaline thermophilic Inorganic pyrophosphatase (Inorganic pyrophosphatase, PPase, EC3.6.1.1) and application thereof in Polymerase Chain Reaction (PCR) enhancement and UDP-galactose synthesis. The alkaline thermophilic Inorganic pyrophosphatase (Inorganic pyrophosphatase, PPase, EC3.6.1.1) is obtained by screening thermophilic bacteria Thermococcus onnenuineus NA1 in the laboratory, is marked as alkaline thermophilic PPase Ton1914, and the nucleotide sequence of the alkaline thermophilic Inorganic pyrophosphatase is shown as SEQ ID No. 1.
The alkaline thermophilic PPase Ton1914 is prepared by the following steps:
(1) obtaining an alkaline thermophilic PPase Ton1914 gene sequence (537bp, code 178aa, SEQ ID No.1) from thermophilic bacteria Thermococcus orniferus NA1 by NCBI GenBank search;
(2) designing a primer according to the nucleotide sequence SEQ ID No.1 of the enzyme, and amplifying the enzyme gene by utilizing PCR;
(3) connecting the recombinant plasmid with an escherichia coli expression vector pET28a to construct a recombinant plasmid, and transforming escherichia coli expression host bacteria BL21(DE3) competent cells to construct recombinase expression bacteria;
(4) the constructed recombinant enzyme expression bacteria are induced by an inducer IPTG (isopropyl thiogalactoside) to express the thermophilic inorganic pyrophosphatase. The expression product is soluble protein in cells, and the alkaline thermophilic PPase Ton1914 is obtained by separating and purifying through cell ultrasonic disruption and heating inactivation.
The second technical scheme of the invention is as follows: the optimum temperature, optimum pH, thermal stability and pH stability of the alkaline thermophilic PPase Ton1914 catalytic reaction are measured by the following specific operations:
(1) the optimal reaction temperature of the alkaline thermophilic PPase Ton1914 is explored by measuring the rate of recombinase catalyzing substrate hydrolysis within the range of 20-90 ℃, and the optimal pH of the alkaline thermophilic PPase Ton1914 is measured within the pH range of 6.0-11.0; the activity assay is described in example 2.
(2) Incubating alkaline thermophilic PPase Ton1914 at 70 ℃, 80 ℃ and 90 ℃ for different times, sampling, determining the residual activity of the alkaline thermophilic PPase Ton1914, and exploring the thermal stability of the alkaline thermophilic PPase Ton 1914; the activity assay is described in example 2.
(3) Respectively incubating alkaline thermophilic PPase Ton1914 in a buffer solution with the pH value of 6-11 for 1h and 24h, sampling and detecting the residual enzyme activity, and exploring the pH stability of the Ton 1914. The activity assay is described in example 2.
The invention provides a strategy for enhancing PCR amplification efficiency by detecting the enhancement effect of thermophilic alkaline inorganic pyrophosphatase on DNA fragments with the amplification product length of 500-6700 bp by utilizing Real-time fluorescence Quantitative (qPCR). The addition of alkaline thermophilic inorganic pyrophosphatase in the reaction for synthesizing UDP-galactose can improve the conversion rate of the reaction and provides a strategy for improving the yield of UDP-galactose.
The third technical scheme of the invention is as follows: the application of the alkaline thermophilic PPase Ton1914 in enhancing the PCR amplification efficiency is to add the alkaline thermophilic PPase Ton1914 into a PCR system to improve the reaction efficiency. The method comprises the following steps:
(1) the concentrations of 7 plasmid templates for amplifying fragments with different lengths, which are stored in a laboratory and can normally express proteins, are determined, and comprise pET28 a-Ttu 2902 (the length of an amplified fragment is 516bp), pET28a-GS01315 (the length of the amplified fragment is 954bp), pET28a-Aaci0783 (the length of the amplified fragment is 1215bp), pET28a-ST0779 (the length of the amplified fragment is 1756bp), pET28a-TL08779 (the length of the amplified fragment is 2494bp), pET28a-2552 (the length of the amplified fragment is 3162bp) and pET28 a-0602C 55S (the length of the amplified fragment is 6710 bp). Plasmid templates were obtained as exemplified by pET28a-Tfu 2902: obtaining a Ttu 2902 gene sequence through NCBI GenBank search, designing a primer according to the Ttu 2902 gene nucleotide sequence, and amplifying the gene by using PCR; the recombinant plasmid is connected with an escherichia coli expression vector pET28a after restriction enzyme digestion to construct a recombinant plasmid, namely a plasmid template pET28 a-Ttu 2902. The other six plasmid templates were obtained in a similar manner. The template concentration is 0.2-0.3 ng/. mu.L, the primer concentration is 300-500 nM, the PCR amplification efficiency is better, and finally the subsequent experiment is carried out by using the template concentration of 0.25 ng/. mu.L and the primer concentration of 300 nM.
(2) Optimizing the adding amount of alkaline thermophilic PPase Ton1914 in a PCR system: in the PCR, enzyme gradient addition (final concentration): 0 ng/mL-1.5 ng/mL. PCR amplification was performed by adding diluted Ton1914 to pET28a-Tfu2902 available in the laboratory as a template. The result confirms that the enzyme amount of 0.5-1.1 ng/mL has better promotion effect on PCR amplification efficiency, and finally 0.7ng/mL is selected to be added into a subsequent reaction system.
(3) Promotion of PCR efficiency for amplification of different fragment lengths by alkaline thermophilic PPase Ton 1914: qPCR was performed using 7 recombinant plasmids of different lengths obtained in step (1) as templates, and the effect of alkaline thermophilic PPase Ton1914 on the enhancement of PCR efficiency for amplifying different fragment lengths was investigated.
The fourth technical scheme of the invention is as follows: the use of alkaline thermophilic PPase Ton1914 in reactions for the synthesis of UDP-galactose.
UDP-sugar pyrophosphorylase TTE0732 can catalyze the reaction of 1-P-galactose (1-P-Gal) and UTP to produce UDP-galactose (UDP-Gal) (patent application No. 202110560931.7): 1-P-Gal + UTP → UDP-Gal + PPi. The reaction conversion rate can be further improved by adding alkaline thermophilic PPase Ton1914 to the reaction.
Drawings
FIG. 1: the optimum reaction temperature curve of alkaline thermophilic PPase Ton 1914; the abscissa is temperature and the ordinate is relative enzyme activity. The enzyme activity is rapidly improved at the temperature of more than 60 ℃, the relative activity of the enzyme can reach more than 95% at 70-80 ℃, the maximum enzyme activity is reached at 80 ℃, and 50% of the maximum enzyme activity can be reached at 80-90 ℃. The alkaline thermophilic PPase Ton1914 in the invention has catalytic activity at high temperature and can be used for removing PPi in PCR reaction.
FIG. 2: the optimum reaction pH curve of alkaline thermophilic PPase Ton 1914; the abscissa is pH value and the ordinate is relative enzyme activity. The enzyme activity is rapidly improved when the pH value reaches more than 8.0, the maximum activity is reached when the pH value reaches 9.0, and the enzyme activity can reach more than 40 percent of the maximum activity within the range of pH 8.0-9.5. It is demonstrated that alkaline thermophilic PPase Ton1914 can maintain higher activity under the PCR reaction condition.
FIG. 3: thermal stability curve of alkaline thermophilic PPase Ton 1914; the inset is the thermal stability curve of base Ton1914 at 70 ℃, with time on the abscissa and relative enzyme activity on the ordinate. The half-life period at 70 ℃ was 52h, and at 80 ℃ and 90 ℃ was 7h and 2.5h, respectively. It was demonstrated that alkaline thermophilic PPase Ton1914 is fully resistant to the high temperature denaturation step of the PCR reaction and remains highly active throughout the PCR reaction.
FIG. 4: pH stability curve of alkaline thermophilic PPase Ton 1914; the abscissa is pH value and the ordinate is relative enzyme activity. Wherein the dotted line is the pH stability curve for 1h and the solid line is the pH stability curve for 24 h. After incubation for 24h in the pH range of 7.0-10.0, the enzyme activity keeps more than 80% of the original activity, which indicates that the alkaline thermophilic PPase Ton1914 has high pH stability.
Fig. 5 to 11: an enhancement effect diagram of the alkaline thermophilic PPase Ton1914 on the PCR amplification efficiency of the amplified fragment with the length of 516-6710 bp; the templates used in fig. 5 to 11 are: pET28 a-Ttu 2902 (length of amplified fragment is 516bp), pET28a-GS01315 (length of amplified fragment is 954bp), pET28a-Aaci0783 (length of amplified fragment is 1215bp), pET28a-ST0779 (length of amplified fragment is 1756bp), pET28a-TL08779 (length of amplified fragment is 2494bp), pET28a-2552 (length of amplified fragment is 3162bp), pET28a-Tn0602C55S (length of amplified fragment is 6710 bp). a is a qPCR fluorescence spectrum showing the amount of product produced with increasing number of qPCR cycles, with the abscissa being the number of PCR amplification cycles and the ordinate being the change in fluorescence intensity; and b is an agarose gel electrophoresis image after qPCR is finished, wherein 1 and 2 are respectively the reaction system without adding alkaline thermophilic PPase Ton1914 and with adding alkaline thermophilic PPase Ton1914, and M is a nucleic acid marker. The result shows that the alkaline thermophilic PPase Ton1914 has obvious promotion effect on the amplification efficiency of DNA fragments with different lengths, and the product quantity is obviously higher than that of the group without the alkaline thermophilic PPase Ton 1914.
Detailed Description
Example 1: the construction of alkaline thermophilic PPase Ton1914 engineering bacteria and the expression and purification of protein comprise the following steps:
cloning of alkaline thermophilic PPase Ton1914 Gene
The alkaline thermophilic PPase Ton1914 primer sequence is as follows:
an upstream primer: 5' AGCATGCCATGGTGAACCCGTTCCAC 3'
A downstream primer: 5' GGACCGCTCGAGCTCCTTCTTACCGAAC 3'
The upstream endonuclease site is Nco I (underlined), and the downstream endonuclease site is Xho I (underlined);
table 1: PCR system
Reagent | Volume (μ L) |
Distilled Water (DW) | 68 |
5× |
20 |
|
8 |
|
1 |
|
1 |
Genomic DNA (laboratory preservation) | 1 |
|
1 |
PCR conditions were as follows: 94 ℃ for 3 min; 94 ℃, 30s, 60 ℃, 30s, 72 ℃, 1min, 30 cycles; 72 ℃ for 10 min; and preserving at 4 ℃.
Expression purification of alkaline thermophilic PPase Ton1914
The alkaline thermophilic PPase Ton1914 PCR product is cut by restriction enzymes Nco I and Xho I, 5 mu L of 10 XBuffer, 25 mu L of PCR product, 1.5 mu L of each restriction enzyme and 15 mu L of distilled water are added in sequence in the cutting system, and the mixture is cut by enzyme for 6h at 37 ℃ after being mixed evenly. mu.L of alkaline thermophilic PPase Ton1914 enzyme digestion product and 3. mu.L of pET28a carrier fragment, 1. mu.L of 10 XT4DNA buffer and 1. mu. L T4The DNA Ligase was mixed and ligated overnight at 16 ℃. mu.L of the ligation mixture was used to transform 100. mu.L of E.coli competent cell DH 5. alpha. and recombinant plasmids were selected. Transforming the recombinant plasmid into Escherichia coli competent cell BL21(DE3), and culturing to OD600When the concentration is 0.6-1.0, 0.5mM IPTG is added to the mixture to carry out shaking culture at 25 ℃ overnight, and the expression of the target protein is induced. The expressed protein is subjected to cell disruption, centrifugation at 12000rpm for 15min, and heat treatment at 80 ℃ for 10min to obtain the alkaline thermophilic PPase Ton1914 pure protein.
The methods of plasmid extraction, E.coli competent cell preparation and vector transformation were referred to "molecular cloning protocols" (third edition, scientific Press, 2002).
Example 2: determination of optimum temperature, optimum pH, thermal stability and pH stability of alkaline thermophilic PPase Ton1914
1. Determination of optimum reaction temperature
The optimal reaction temperature of alkaline thermophilic PPase Ton1914 is explored by measuring the rate of substrate hydrolysis catalyzed by recombinase at 20-90 ℃. To the reaction system were added 4mL of 50mM Tris-HCl (pH 9.0), 1mL of 10mM sodium pyrophosphate, and 10mM MgCl in this order21mL and alkaline thermophilic PPase Ton19140.1mL, mixing uniformly, reacting at different temperatures for 10 minutes, placing on ice to stop reaction, and taking 1mL of reaction solution for activity determination. The activity determination method comprises the following steps: formation of phosphomolybdic acid by reaction of orthophosphate with ammonium molybdate, FeSO under mild acid conditions4The phosphate, the hydrolysis product of PPi, was detected on the principle of reduction to a blue compound and an absorption peak at 660 mm. 5mL of ammonium molybdate-FeSO was added to the reaction system4The color developing agent is a color developing substrate, and 1mL of the reaction solution and deionized water are added to make up a 10mL system. The control group did not contain alkaline thermophilic PPase Ton1914, and the other components were identical to those of the experimental group. After incubation at room temperature for 10min, the reacted experimental group and control group were transferred to a 1mL cuvette and absorbance at 660nm was measured in a spectrophotometer.
2. Determination of optimum reaction pH
The optimum reaction pH of alkaline thermophilic PPase Ton1914 was measured in the range of pH 6.0-11.0, and the activity was measured at 70 ℃ in 50mM Tris-HCl buffer (pH6.0, 7.0, 8.0 and 9.0) and 50mM Gly-NaOH buffer (pH 9.0, 10.0 and 11.0). The system and method for determining viability are the same as above.
3. Determination of thermal stability
The alkaline thermophilic PPase Ton1914 is incubated at 70 ℃, 80 ℃ and 90 ℃, samples are taken at intervals of 0.5h, 2h and 4h respectively, and the thermal stability of the enzyme within 100h is detected. The system and method for determining viability are the same as above.
Determination of pH stability
And (3) measuring the pH stability of the alkaline thermophilic PPase Ton1914 within the range of pH 6.0-11.0, wherein the incubation time is 1h and 24h, and sampling to detect the residual enzyme activity. The system and method for determining viability are the same as above.
Example 3: application of alkaline thermophilic PPase Ton1914 in enhancing PCR efficiency
Alkaline thermophilic PPase Ton1914 with the final concentration of 0 ng/mL-1.5 ng/mL was added to the system of Table 2 using pET28a-Tfu2902 recombinant plasmid as a template, and qPCR was performed to determine the amount of alkaline thermophilic PPase Ton1914 added.
Table 2: qPCR reaction system dosage scale
Reagent | Volume (μ L) |
Premixed liquid of |
10 |
|
2 |
|
2 |
Sterile Water/ |
2 |
|
4 |
Adding 10 mu L of the premixed solution of the kit and 4 mu L of the plasmid template pET28a-Tfu2902 into a PCR tube, sequentially adding 2 mu L of each of the upstream primer and the downstream primer, finally adding 2 mu L of alkaline thermophilic PPase Ton1914 with different concentrations, and uniformly mixing to perform qPCR. Reaction procedure for qPCR: at 50 ℃ for 2 min; pre-denaturation at 95 ℃ for 2 min; denaturation at 95 ℃ for 15s, annealing/extension at 60 ℃ for 1 min; return to denaturation and repeat for 30 cycles; and preserving at 4 ℃. After the amplification, the detection of the amplified product was performed by 0.8% agarose gel electrophoresis. Finally, the effect of promoting the PCR amplification efficiency by the addition amount of 0.5-1.1 ng/mL of alkaline thermophilic PPase Ton1914 is determined to be good, and the addition amount of 0.7ng/mL is selected for carrying out the later experiment.
Determination of the concentration of 7 plasmid templates: pET28a-Tfu2902, pET28a-GS01315, pET28a-Aaci0783, pET28a-ST0779, pET28a-TL08779, pET28a-2552 and pET28a-Tn0602C55S are selected as templates for PCR amplification, templates with different concentrations are added into a PCR system, and the PCR system is subjected to PowerUp detectionTM SYBRTMThe Green Master Mix kit is operated according to the instruction, the result shows that the template concentration is 0.2-0.3 ng/mu L, the primer concentration is 300-500 nM, the PCR amplification efficiency is better, and finally the subsequent experiment is carried out according to the template concentration of 0.25 ng/mu L and the primer concentration of 300 nM. When qPCR is carried out, 10 mu L of kit premix solution is firstly added, 4 mu L of template (the final concentration is 0.25 ng/mu L), 2 mu L of each of the upstream primer and the downstream primer is then sequentially added, and finally 2 mu L of alkaline thermophilic PPase Ton1914 (the final concentration is 0.7ng/mL) is added, qPCR is carried out after uniform mixing, and the promotion effect of the alkaline thermophilic PPase Ton1914 on the PCR efficiency of amplifying products with different lengths is researched through analyzing the product quantity by a fluorescence spectrum and agarose gel electrophoresis. The control group was not supplemented with alkaline thermophilic PPase Ton1914, and the other components were the same as those in the experimental group. The template was 7 recombinant plasmids described in 2, where pET28a-Tfu290 was used to amplify a product of 516bp in length, pET28a-GS01315 was used to amplify a product of 954bp in length, pET28a-Aaci0783 was used to amplify a product of 1215bp in length, pET28a-ST0779 was used to amplify a product of 1756bp in length, pET28a-TL08779 was used to amplify a product of 2494bp in length, pET28a-2522 was used to amplify a product of 3162bp in length, and pET28a-Tn0602C55S was used to amplify a product of 6710bp in length. The results show that the alkaline thermophilic PPase Ton1914 has the promotion effect on the reactions, and the product amount is obviously higher than that of the group without the alkaline thermophilic PPase Ton 1914.
Example 4: application of alkaline thermophilic PPase Ton1914 in reaction for synthesizing UDP-galactose
UDP-sugar pyrophosphorylase TTE0732 can catalyze the reaction of 1-P-galactose (1-P-Gal) and UTP to generate UDP-galactose (UDP-Gal): 1-P-Gal + UTP → UDP-Gal + PPi. Further, alkaline thermophilic PPase Ton1914 was added to the reaction to increase the reaction conversion. The composition data of the reaction system are shown in Table 2:
table 3: compositional data of the reaction System
Reaction conditions are as follows: incubating at 50 ℃ for 5h, terminating the reaction after the reaction is finished in a boiling water bath for 1min, centrifuging at 12000rpm for 3min, collecting supernatant, and passing through a 0.22 mu m water film for HPLC liquid phase detection of the residual UTP. The results of the experiment showed that the conversion rate of the reaction (conversion rate ═ UTP) was obtained after addition of alkaline thermophilic PPase Ton1914(blank group)-UTP(Experimental group))/UTP (blank group)100%) increased from 30% in experimental group 1 to 57% in experimental group 2.
The present disclosure is believed to provide those skilled in the art with a full range of applicability. The foregoing preferred embodiments are therefore to be understood as merely illustrative and not limiting of the scope of the invention in any way.
<110> Jilin university
<120> alkaline thermophilic inorganic pyrophosphatase and its use for enhancing polymerase chain reaction and synthesis of UDP-galactose
<160> 2
<170> PatentIn version 3.5
<210> 1
<211> 537
<212> DNA
<213> Thermococcus onnurineus NA1
<221> CDS
<222> (1)..(537)
<400> 1
atg aac ccg ttc cac gag ctt gag ccc gga ccg gag gtt cca gag gtc 48
Met Asn Pro Phe His Glu Leu Glu Pro Gly Pro Glu Val Pro Glu Val
1 5 10 15
gtt tac gct ctt ata gag att ccg aag gga agc agg aac aag tac gag 96
Val Tyr Ala Leu Ile Glu Ile Pro Lys Gly Ser Arg Asn Lys Tyr Glu
20 25 30
ctc gac aag aag acc ggc ctt ctc aag ctt gat aga gtg ctc tac agc 144
Leu Asp Lys Lys Thr Gly Leu Leu Lys Leu Asp Arg Val Leu Tyr Ser
35 40 45
ccg ttc ttc tac ccg gtt gac tac gga atc atc ccg cag acc tgg tac 192
Pro Phe Phe Tyr Pro Val Asp Tyr Gly Ile Ile Pro Gln Thr Trp Tyr
50 55 60
gac gac ggc gac ccc ttt gac ata atg gtc atc atg cgc gag ccg gtc 240
Asp Asp Gly Asp Pro Phe Asp Ile Met Val Ile Met Arg Glu Pro Val
65 70 75 80
tac ccg ctc acc atc gtc gag gcc agg ccg ata ggc atc atg aag atg 288
Tyr Pro Leu Thr Ile Val Glu Ala Arg Pro Ile Gly Ile Met Lys Met
85 90 95
gag gac agc gga gac aaa gac tgg aag gtt ctc gcc gtt ccc gtc gag 336
Glu Asp Ser Gly Asp Lys Asp Trp Lys Val Leu Ala Val Pro Val Glu
100 105 110
gat ccg tac ttc aat gac tgg aag gac atc gac gac gtt ccg aag gcc 384
Asp Pro Tyr Phe Asn Asp Trp Lys Asp Ile Asp Asp Val Pro Lys Ala
115 120 125
ttc ctt gac gag ata gcc cac ttc ttc cag agg tac aag gag ctc cag 432
Phe Leu Asp Glu Ile Ala His Phe Phe Gln Arg Tyr Lys Glu Leu Gln
130 135 140
ggc aaa gtc acc acc gtc gaa ggc tgg ggc acc gcc gag gag gcc aag 480
Gly Lys Val Thr Thr Val Glu Gly Trp Gly Thr Ala Glu Glu Ala Lys
145 150 155 160
agg gaa atc ctc agg gcc atc gag atg tac aaa gag aag ttc ggt aag 528
Arg Glu Ile Leu Arg Ala Ile Glu Met Tyr Lys Glu Lys Phe Gly Lys
165 170 175
aag gag tga 537
Lys Glu
Claims (3)
1. An alkaline thermophilic PPase Ton1914, the nucleotide sequence of which is shown in SEQ ID No. 1.
2. Use of the alkaline thermophilic PPase Ton1914 according to claim 1 for enhancing the polymerase chain reaction.
3. Use of the alkaline thermophilic PPase Ton1914 according to claim 1 in reactions for the synthesis of UDP-galactose.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110765804.0A CN113481180A (en) | 2021-07-05 | 2021-07-05 | Alkaline thermophilic inorganic pyrophosphatase and application thereof in enhancing polymerase chain reaction and UDP-galactose synthesis reaction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110765804.0A CN113481180A (en) | 2021-07-05 | 2021-07-05 | Alkaline thermophilic inorganic pyrophosphatase and application thereof in enhancing polymerase chain reaction and UDP-galactose synthesis reaction |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113481180A true CN113481180A (en) | 2021-10-08 |
Family
ID=77941681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110765804.0A Pending CN113481180A (en) | 2021-07-05 | 2021-07-05 | Alkaline thermophilic inorganic pyrophosphatase and application thereof in enhancing polymerase chain reaction and UDP-galactose synthesis reaction |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113481180A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114507649A (en) * | 2022-02-16 | 2022-05-17 | 吉林大学 | Thermophilic enzyme and method for efficiently synthesizing UDP-glucose and UDP-glucuronic acid by one-pot method |
Citations (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9208211D0 (en) * | 1991-05-31 | 1992-05-27 | Ciba Geigy Ag | Improved process for the production of glycosyltransferases |
US5264352A (en) * | 1991-04-09 | 1993-11-23 | Hoechst Aktiengesellschaft | Process for the enzymatic synthesis of 2-deoxy-β-D-galactosides |
WO1996012798A1 (en) * | 1994-10-25 | 1996-05-02 | New England Biolabs, Inc. | Purified thermostable inorganic pyrophosphatase obtainable from thermococcus litoralis |
WO1997037038A1 (en) * | 1996-03-29 | 1997-10-09 | Boehringer Mannheim Gmbh | Process for the specific multiplication of long nucleic acids by pcr |
US20020025560A1 (en) * | 1996-09-17 | 2002-02-28 | Satoshi Koizumi | Processes for producing sugar nucleotides and complex carbohydrates |
US20020034805A1 (en) * | 1997-12-15 | 2002-03-21 | Michel Gilbert | Fusion proteins for use in enzymatic synthyesis of oligosaccharides |
US20020132320A1 (en) * | 2001-01-10 | 2002-09-19 | Wang Peng George | Glycoconjugate synthesis using a pathway-engineered organism |
US20020150968A1 (en) * | 2001-01-10 | 2002-10-17 | Wang Peng G. | Glycoconjugate and sugar nucleotide synthesis using solid supports |
US20030049655A1 (en) * | 2001-04-30 | 2003-03-13 | Clark Duncan Roy | Amplification process |
JP2003189891A (en) * | 1996-09-17 | 2003-07-08 | Kyowa Hakko Kogyo Co Ltd | Method for producing sugar nucleotide and complex carbohydrate |
AU2003280261A8 (en) * | 2002-11-08 | 2004-06-07 | Affinium Pharm Inc | Crystal structures of bacterial inorganic pyrophosphatases |
CN1668739A (en) * | 2002-07-15 | 2005-09-14 | 纳瓦拉公立大学 | Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (NPPase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants |
WO2007057167A2 (en) * | 2005-11-18 | 2007-05-24 | Bioline Limited | A method for enhancing enzymatic dna polymerase reactions |
KR20080047754A (en) * | 2006-11-27 | 2008-05-30 | (주)바이오니아 | Thermostable pyrophosphatase from picrophilus torridus |
US7901912B1 (en) * | 2004-10-21 | 2011-03-08 | Yamasa Corporation | Method of producing uridine 5′-diphospho-N-acetylgalactosamine |
CN102858965A (en) * | 2010-04-30 | 2013-01-02 | 霍夫曼-拉罗奇有限公司 | System and method for purification and use of inorganic pyrophosphatase from aquifex aeolicus |
US20150044683A1 (en) * | 2012-03-09 | 2015-02-12 | Bioneer Corporation | Composition for hot-start reverse transcription reaction or hot-start reverse transcription polymerase chain reaction |
CN104862288A (en) * | 2015-05-08 | 2015-08-26 | 苏州大学 | Synthesis of novel temperature-responsive inorganic pyrophosphatase conjugate and application of conjugate in enhanced polymerase chain reaction |
CN105821017A (en) * | 2016-03-31 | 2016-08-03 | 中国农业科学院作物科学研究所 | Application of maize pyrophosphorylase gene ZmPPase 4 to improvement of plant stress resistance |
WO2017070164A2 (en) * | 2015-10-19 | 2017-04-27 | University Of Florida Research Foundation, Incorporated | A thermostable haloarchaeal inorganic pyrophosphatase |
CN106834249A (en) * | 2017-01-10 | 2017-06-13 | 广州海力特生物科技有限公司 | A kind of thermally-stabilised inorganic pyrophosphatase of transformation |
CN108998403A (en) * | 2018-09-19 | 2018-12-14 | 长春大学 | A kind of bacillus subtilis recombinant bacterium and its application |
WO2021089251A1 (en) * | 2019-11-05 | 2021-05-14 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Enzymatic method for preparation of udp-galactose |
CN113265434A (en) * | 2021-05-19 | 2021-08-17 | 吉林大学 | Method for synthesizing UDP-galactose and galactosyl compound |
CN114507649A (en) * | 2022-02-16 | 2022-05-17 | 吉林大学 | Thermophilic enzyme and method for efficiently synthesizing UDP-glucose and UDP-glucuronic acid by one-pot method |
WO2023250198A1 (en) * | 2022-06-24 | 2023-12-28 | Zymtronix Catalytic Systems, Inc. | Biocatalytic manufacture of sugar nucleotides |
-
2021
- 2021-07-05 CN CN202110765804.0A patent/CN113481180A/en active Pending
Patent Citations (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5264352A (en) * | 1991-04-09 | 1993-11-23 | Hoechst Aktiengesellschaft | Process for the enzymatic synthesis of 2-deoxy-β-D-galactosides |
GB9208211D0 (en) * | 1991-05-31 | 1992-05-27 | Ciba Geigy Ag | Improved process for the production of glycosyltransferases |
WO1996012798A1 (en) * | 1994-10-25 | 1996-05-02 | New England Biolabs, Inc. | Purified thermostable inorganic pyrophosphatase obtainable from thermococcus litoralis |
US5861296A (en) * | 1994-10-25 | 1999-01-19 | New England Biolabs, Inc. | Purified thermostable inorganic pyprophosphatase obtainable from thermococcus litoralis |
WO1997037038A1 (en) * | 1996-03-29 | 1997-10-09 | Boehringer Mannheim Gmbh | Process for the specific multiplication of long nucleic acids by pcr |
JP2003189891A (en) * | 1996-09-17 | 2003-07-08 | Kyowa Hakko Kogyo Co Ltd | Method for producing sugar nucleotide and complex carbohydrate |
US20020025560A1 (en) * | 1996-09-17 | 2002-02-28 | Satoshi Koizumi | Processes for producing sugar nucleotides and complex carbohydrates |
CN1550554A (en) * | 1996-09-17 | 2004-12-01 | Э�ͷ���ҵ��ʽ���� | Processes for producing sugar nucleotides and complex carbohydrates |
US20020034805A1 (en) * | 1997-12-15 | 2002-03-21 | Michel Gilbert | Fusion proteins for use in enzymatic synthyesis of oligosaccharides |
US20020150968A1 (en) * | 2001-01-10 | 2002-10-17 | Wang Peng G. | Glycoconjugate and sugar nucleotide synthesis using solid supports |
US20020132320A1 (en) * | 2001-01-10 | 2002-09-19 | Wang Peng George | Glycoconjugate synthesis using a pathway-engineered organism |
US20030049655A1 (en) * | 2001-04-30 | 2003-03-13 | Clark Duncan Roy | Amplification process |
CN1522305A (en) * | 2001-04-30 | 2004-08-18 | Amplification process | |
CN1668739A (en) * | 2002-07-15 | 2005-09-14 | 纳瓦拉公立大学 | Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (NPPase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants |
AU2003280261A8 (en) * | 2002-11-08 | 2004-06-07 | Affinium Pharm Inc | Crystal structures of bacterial inorganic pyrophosphatases |
US7901912B1 (en) * | 2004-10-21 | 2011-03-08 | Yamasa Corporation | Method of producing uridine 5′-diphospho-N-acetylgalactosamine |
WO2007057167A2 (en) * | 2005-11-18 | 2007-05-24 | Bioline Limited | A method for enhancing enzymatic dna polymerase reactions |
KR20080047754A (en) * | 2006-11-27 | 2008-05-30 | (주)바이오니아 | Thermostable pyrophosphatase from picrophilus torridus |
CN102858965A (en) * | 2010-04-30 | 2013-01-02 | 霍夫曼-拉罗奇有限公司 | System and method for purification and use of inorganic pyrophosphatase from aquifex aeolicus |
US20150044683A1 (en) * | 2012-03-09 | 2015-02-12 | Bioneer Corporation | Composition for hot-start reverse transcription reaction or hot-start reverse transcription polymerase chain reaction |
CN104862288A (en) * | 2015-05-08 | 2015-08-26 | 苏州大学 | Synthesis of novel temperature-responsive inorganic pyrophosphatase conjugate and application of conjugate in enhanced polymerase chain reaction |
WO2017070164A2 (en) * | 2015-10-19 | 2017-04-27 | University Of Florida Research Foundation, Incorporated | A thermostable haloarchaeal inorganic pyrophosphatase |
CN105821017A (en) * | 2016-03-31 | 2016-08-03 | 中国农业科学院作物科学研究所 | Application of maize pyrophosphorylase gene ZmPPase 4 to improvement of plant stress resistance |
CN106834249A (en) * | 2017-01-10 | 2017-06-13 | 广州海力特生物科技有限公司 | A kind of thermally-stabilised inorganic pyrophosphatase of transformation |
CN108998403A (en) * | 2018-09-19 | 2018-12-14 | 长春大学 | A kind of bacillus subtilis recombinant bacterium and its application |
WO2021089251A1 (en) * | 2019-11-05 | 2021-05-14 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Enzymatic method for preparation of udp-galactose |
CN114641577A (en) * | 2019-11-05 | 2022-06-17 | 马克斯·普朗克科学促进学会 | Enzymatic process for the preparation of UDP-galactose |
CN113265434A (en) * | 2021-05-19 | 2021-08-17 | 吉林大学 | Method for synthesizing UDP-galactose and galactosyl compound |
CN114507649A (en) * | 2022-02-16 | 2022-05-17 | 吉林大学 | Thermophilic enzyme and method for efficiently synthesizing UDP-glucose and UDP-glucuronic acid by one-pot method |
WO2023250198A1 (en) * | 2022-06-24 | 2023-12-28 | Zymtronix Catalytic Systems, Inc. | Biocatalytic manufacture of sugar nucleotides |
Non-Patent Citations (16)
Title |
---|
JIANBO ZHANG等: "Large-scale Synthesis of Carbohydrates for Pharmaceutical Development", CURRENT ORGANIC CHEMISTRY, vol. 2000, 1 December 2001 (2001-12-01), pages 1169 - 1176 * |
LEE, H.S.等: "Thermococcus onnurineus NA1, complete genome", GENBANK DATABASE, 31 January 2014 (2014-01-31), pages 000855 * |
LEE,H.S.等: "Thermococcus onnurineus NA1, complete genome", 《GENBANK DATABASE》 * |
LEE,H.S.等: "Thermococcus onnurineus NA1, complete genome", 《GENBANK DATABASE》, 31 January 2014 (2014-01-31), pages 000855 * |
SUN YOUNG PARK等: "Facilitation of polymerase chain reaction with thermostable inorganic pyrophosphatase from hyperthermophilic archaeon Pyrococcus horikoshii", 《APPL MICROBIOL BIOTECHNOL》, vol. 85, 31 October 2009 (2009-10-31), pages 807 - 812, XP019778604 * |
YANG ZOU等: "One-pot three-enzyme synthesis of UDP-Glc, UDP-Gal, and their derivatives", CARBOHYDRATE RESEARCH, 24 May 2013 (2013-05-24), pages 76 - 81 * |
刘原子等: "腾冲嗜热厌氧杆菌tte0732 基因的表达及生物信息学分析", 微生物杂志, vol. 38, no. 1, 15 February 2018 (2018-02-15), pages 44 * |
刘春红等: "平贝母多糖对D-半乳糖诱导衰老模型小鼠的抗氧化作用", 《食品科学》 * |
刘春红等: "平贝母多糖对D-半乳糖诱导衰老模型小鼠的抗氧化作用", 《食品科学》, no. 23, 15 December 2011 (2011-12-15), pages 292 - 295 * |
尹恒等: "茶尺蠖无机焦磷酸酶EoPPase672的表达与功能研究", 《昆虫学报》 * |
尹恒等: "茶尺蠖无机焦磷酸酶EoPPase672的表达与功能研究", 《昆虫学报》, vol. 65, no. 4, 24 April 2022 (2022-04-24), pages 427 - 436 * |
王迎华;曹郁生;陈燕;高丹丹;: "galU基因在乳酸乳球菌中的克隆及其对胞外多糖产生的影响", 天然产物研究与开发, no. 04, 15 August 2009 (2009-08-15), pages 1 - 6 * |
王鸿利等主编: "《中华检验医学大辞典》", vol. 2000, 上海科学技术出版社, pages: 48 * |
舍英著: "《应用同功酶学》", 31 December 2001, 内蒙古人民出版社, pages: 350 - 352 * |
许韶华等: "糖基转移酶活性供体UDP-糖的生物合成及循环再生", 《药物生物技术》 * |
许韶华等: "糖基转移酶活性供体UDP-糖的生物合成及循环再生", 《药物生物技术》, vol. 26, no. 3, 15 June 2019 (2019-06-15), pages 244 - 249 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114507649A (en) * | 2022-02-16 | 2022-05-17 | 吉林大学 | Thermophilic enzyme and method for efficiently synthesizing UDP-glucose and UDP-glucuronic acid by one-pot method |
CN114507649B (en) * | 2022-02-16 | 2023-11-21 | 吉林大学 | Thermophilic enzyme and method for efficiently synthesizing UDP-glucose and UDP-glucuronic acid by one-pot method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113862233B (en) | Method for improving acid stability of glucose oxidase, mutant Q241E/R499E, gene and application | |
CN113151198B (en) | Gamma-glutamine synthetase mutant, coding gene, amino acid sequence and application thereof | |
CN114736879B (en) | Glucose oxidase GoxM10 mutant E361P with improved heat stability and derivative mutant and application thereof | |
JP2024057009A (en) | Engineered DNA polymerase variants | |
JP2019509766A (en) | Marine organism DNA polymerase | |
CN113481180A (en) | Alkaline thermophilic inorganic pyrophosphatase and application thereof in enhancing polymerase chain reaction and UDP-galactose synthesis reaction | |
US20110045542A1 (en) | Amplification of bisulfite-reacted nucleic acids | |
US20230063705A1 (en) | Methods and kits for amplification and detection of nucleic acids | |
CN108118038A (en) | A kind of glucose oxidase mutant | |
CN114736880B (en) | Mutant D497N of glucose oxidase GoxM10 with improved acid stability as well as derivative mutant and application thereof | |
CN114736881B (en) | Glucose oxidase GoxM10 mutant A4D with improved acid stability and derivative mutant and application thereof | |
US11788068B2 (en) | Modified/mutant bacterial luciferases | |
CN107760736B (en) | Method for promoting indigo biosynthesis conversion yield | |
CN113528626B (en) | Method for synthesizing nucleic acid | |
Yan et al. | Characterization of a family I-liked alkaline-resistant inorganic pyrophosphatase from the hyperthermophilic archaeon Pyrococcus furiosus for rapid determination of sugar nucleotidyltransferase at high temperature | |
CN114107246B (en) | Uridine-cytidine kinase mutant and application thereof in production of cytidine acid | |
CN107446907A (en) | A kind of thermophilic Pullulanase and preparation method thereof | |
CN109735511B (en) | Preparation method of xanthine oxidase for clinical detection | |
CN1309827C (en) | Simple efficient and accelerated method for enzyme-catalyzed in vitro modification and synthesis of nucleic acid using microwave irradiation | |
CN113785053B (en) | Reverse transcriptase with increased enzymatic activity and use thereof | |
KR101155368B1 (en) | Nanoarchaeum equitans plus DNA polymerase, method for preparing the same and its PCR method using dUTP and uracil-DNA glycosylase | |
CN117946997A (en) | High-temperature-resistant Bst DNA polymerase mutant and application thereof | |
CN116694542A (en) | Double-enzyme co-expression strain for producing L-malic acid and construction method and application thereof | |
CN115803433A (en) | Thermostable ligases with reduced sequence bias | |
RU2405823C2 (en) | Thermostable dna-ligase of thermococcus archaea, method for producing thereof and dna nucleotide sequence coding such dna-ligase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220715 Address after: 201200 1st floor, unit 3, building 8, No. 160, basheng Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai Applicant after: Xinya Lihua Biotechnology (Shanghai) Co.,Ltd. Address before: 130012 No.2699 Qianjin Street, Changchun hi tech Industrial Development Zone, Changchun City, Jilin Province Applicant before: Jilin University |
|
TA01 | Transfer of patent application right |